Commodore Capital LP Q2 2024 Filing
Filed August 14, 2024
Portfolio Value
$1.5B
Holdings
35
Report Date
Q2 2024
Filing Type
13F-HR
All Holdings (35 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | MRUSMERUS N V | 3,200,000 | $189.3T | 12924434.54% | |
| 2 | NUVLNUVALENT INC | 1,487,756 | $112.9T | 7703792.06% | |
| 3 | XENEXENON PHARMACEUTICALS INC | 2,754,266 | $107.4T | 7330255.60% | |
| 4 | PCVXVAXCYTE INC | 1,305,000 | $98.5T | 6726280.68% | |
| 5 | ELVNENLIVEN THERAPEUTICS INC | 3,973,245 | $92.9T | 6338172.62% | |
| 6 | VERAVERA THERAPEUTICS INC | 2,475,000 | $89.5T | 6112287.44% | |
| 7 | COGTCOGENT BIOSCIENCES INC | 9,738,000 | $82.1T | 5603473.84% | |
| 8 | SLNOSOLENO THERAPEUTICS INC | 1,425,000 | $58.1T | 3968579.01% | |
| 9 | TCE2CELLDEX THERAPEUTICS INC NEW | 1,425,000 | $52.7T | 3599929.15% | |
| 10 | BRD1EURMIND MEDICINE MINDMED INC | 7,145,888 | $51.5T | 3516830.76% | |
| 11 | RYTMRHYTHM PHARMACEUTICALS INC | 1,225,000 | $50.3T | 3433325.96% | |
| 12 | ARVNARVINAS INC | 1,884,361 | $50.2T | 3423987.45% | |
| 13 | SYRESPYRE THERAPEUTICS INC | 1,988,084 | $46.7T | 3190416.37% | |
| 14 | CATXPERSPECTIVE THERAPEUTICS INC | 4,657,345 | $46.4T | 3169520.58% | |
| 15 | PHVSPHARVARIS N V | 1,810,175 | $34.0T | 2322942.26% | |
| 16 | ALKSALKERMES PLC | 1,375,000 | $33.1T | 2261933.04% | |
| 17 | VRDNVIRIDIAN THERAPEUTICS INC | 2,528,032 | $32.9T | 2245018.18% | |
| 18 | KURAKURA ONCOLOGY INC | 1,593,350 | $32.8T | 2239378.69% | |
| 19 | NKTXNKARTA INC | 4,151,034 | $24.5T | 1674571.81% | |
| 20 | CELCCELCUITY INC | 1,464,105 | $24.0T | 1636990.38% | |
| 21 | THRDTHIRD HARMONIC BIO INC | 1,545,426 | $20.1T | 1371360.29% | |
| 22 | IMVTIMMUNOVANT INC | 750,990 | $19.8T | 1353312.47% | |
| 23 | ABVXABIVAX SA | 1,284,110 | $17.0T | 1158760.50% | |
| 24 | SNDXSYNDAX PHARMACEUTICALS INC | 825,000 | $16.9T | 1156119.97% | |
| 25 | CCCCC4 THERAPEUTICS INC | 3,410,384 | $15.8T | 1075487.23% | |
| 26 | ORICORIC PHARMACEUTICALS INC | 2,000,000 | $14.1T | 965182.44% | |
| 27 | APGEAPOGEE THERAPEUTICS INC | 290,000 | $11.4T | 778937.73% | |
| 28 | CABACABALETTA BIO INC | 1,100,000 | $8.2T | 561635.16% | |
| 29 | —PERCEPTIVE CAP SOLUTIONS COR | 750,000 | $7.5T | 515014.25% | |
| 30 | NGNENEUROGENE INC | 200,000 | $7.3T | 496789.10% | |
| 31 | VTGNVISTAGEN THERAPEUTICS INC | 1,575,000 | $5.5T | 374127.65% | |
| 32 | HLXCHELIX ACQUISITION CORP II | 500,000 | $5.1T | 348803.56% | |
| 33 | AUTLAUTOLUS THERAPEUTICS PLC | 1,178,723 | $4.1T | 279995.47% | |
| 34 | ABIOEURARCA BIOPHARMA INC | 414,325 | $1.6T | 108317.84% | |
| 35 | AVTXAVALO THERAPEUTICS INC | 40,000 | $498.8B | 34047.60% |